Market Overview

Why This Analyst Sees Care.com Fetching Up To $16/Share In Potential Sale

Share:
Why This Analyst Sees Care.com Fetching Up To $16/Share In Potential Sale

Care.com Inc (NYSE: CRCM), an online platform to help people find and manage family care, is reportedly undertaking a strategic review and could sell itself in the $14 to $16 per share range, according to BTIG.

The Analyst

BTIG analyst Marvin Fong maintains a Buy rating on Care's stock with a $13 price target.

The Thesis

Care.com appears to be "ripe for a possible sale" of itself given multiple vacant positions in senior management along with frustrated shareholders and pressure from activist investor Engine Capital, Fong wrote in a note.

On the other hand, the company does have a leading platform within an attractive market with a short list of potential buyers, including IAC/InterActiveCorp (NASDAQ: IAC), Internet Brands, or a private equity group.

Fong said a potential buyer would appreciate Care's more enhanced background checks and management's strategy to fight back against recent negative press. The company also boasts a "sound" balance sheet and positive free cash flow.

At this point a sale is "more likely than not" to take place and a price tag of $14 to $16 implies a multiple of 22 to 26 times 2020 estimated Adjusted EBITDA.

Price Action

Shares of Care.com were trading higher by 8.4% Monday at $12.13.

Latest Ratings for CRCM

DateFirmActionFromTo
Nov 2019MaintainsHold
Aug 2019UpgradesNeutralBuy
Jun 2019DowngradesBuyHold

View More Analyst Ratings for CRCM
View the Latest Analyst Ratings

Posted-In: btig Family Care Margin FongAnalyst Color M&A Health Care Analyst Ratings General Best of Benzinga

 

Related Articles (CRCM + IAC)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
OKTACanaccord GenuityMaintains125.0
WLCanaccord GenuityMaintains0.600
TDCanaccord GenuityMaintains79.0
CWBCanaccord GenuityMaintains34.0
CMCanaccord GenuityMaintains108.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Bank Of America Sees Buying Opportunity In Atlassian

Fuller Speed Ahead [podcast] – P.A.M. President & CEO Dan Cushman